29.87USD-1.74%Mkt Cap: 555.25M USDP/E: 1.56Last update: 2026-06-01
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral s…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap555.25M USD
Enterprise Value463.16M USD
Revenue (TTM)299.77M USD
Gross Profit274.66M USD
Net Income (TTM)367.02M USD
Revenue/Share16.53 USD
Last Price29.87 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees172
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS7665596034
Valuation
P/E (Trailing)1.56
P/E (Forward)6.65
PEG—
EV/EBITDA3.65
EV/Revenue1.55
P/S1.88
P/B1.41
EPS (TTM)19.29
EPS (Forward)4.58
52W Range
18.1434% of range52.24
52W High52.24 USD
52W Low18.14 USD
Profitability
Gross Margin93.33%
Oper. Margin20.21%
EBITDA Margin42.36%
Profit Margin124.72%
ROE93.75%
ROA71.46%
Growth
Revenue Growth10.30%
Earnings Growth-30.20%
Cash Flow & Leverage
Operating CF75.66M USD
CapEx (TTM)—
FCF Margin26.20%
FCF Yield14.15%
Net Debt-100.96M USD
Net Debt/EBITDA-0.80
Balance Sheet
Debt/Equity0.14
Current Ratio2.62
Quick Ratio2.20
Book Value/Sh21.64 USD
Cash/Share7.928 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 27, 2024
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)53.20 USD
Target Range38.00 USD – 81.00 USD
# Analysts5
Ownership
Shares Out.18.50M
Float15.95M
Insiders3.28%
Institutions94.57%
Short Interest
Short Ratio9.2d
Short % Float21.90%
Short % Out.21.33%
Shares Short3.95M
Short (prev mo.)4.12M
Technical
SMA 5028.84 (+3.6%)
SMA 20034.67 (-13.8%)
Beta1.20
S&P 52W Chg27.70%
Avg Vol (30d)375.64K
Avg Vol (10d)357.11K
Technical Indicators
RSI (14)55.8
MACD0.1042
MACD Signal-0.0709
MACD Hist.+0.1751
BB Upper32.23 USD
BB Middle28.88 USD
BB Lower25.53 USD
BB Width23.21%
ATR (14)1.556 USD
Vol Ratio (20d)0.44x